The purpose of this study was to research the clinicopathological characteristics and prognosis of ER(-)/PR(+) breast cancer, and construct a nomogram to effectively predict the prognosis of patients, and provide a basis for developing more suitable individualized treatment strategies. This evidence concerns the gene ESR1 and breast cancer.